GlassScriptPhysician profile
Taylor Nielsen
NPI 1548997349
$1,575.63
in general payments reported to CMS, 2019-2025
14 companies · $612 in 2025
The $612 reported for 2025 was more than what 90% of Women'S Health (Nurse Practitioner) providers received nationally (typical 2025 total: $123).
See the full distribution for Women's Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $61.17 · 2023: $98.12 · 2024: $804 · 2025: $612.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,514.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,514.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biogen, INC. | $437.92 | 2024-2025 | Zurzuvae, Vumerity |
| Sumitomo Pharma America, INC. | $220.14 | 2024-2025 | Myfembree, Gemtesa |
| Shield Therapeutics INC | $184.07 | 2024-2025 | |
| Astellas Pharma US INC | $171.63 | 2023-2025 | Veozah |
| Organon LLC | $116.27 | 2022-2025 | Nexplanon |
| Exeltis, USA INC. | $115.20 | 2023-2025 | Slynd |
| Millicent US INC | $88.18 | 2024-2025 | Femlyv, Intrarosa |
| Mayne Pharma Commercial LLC | $55.51 | 2025 | |
| Exact Sciences Corporation | $54.98 | 2024-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Myriad Women'S Health, INC. | $42.66 | 2023 | Myrisk |
| Novo Nordisk INC | $38.33 | 2024 | |
| Evofem Biosciences, INC. | $26.92 | 2025 | Phexxi, Solosec, Phexx |
| Agile Therapeutics, INC. | $14.54 | 2024 | Twirla |
| Channel Medsystems, INC. | $9.28 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Taylor Nielsen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.